Works matching IS 03065251 AND DT 2019 AND VI 85 AND IP 6
Results: 37
Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1213, doi. 10.1111/bcp.13921
- By:
- Publication type:
- Article
Issue highlights.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1047, doi. 10.1111/bcp.13978
- Publication type:
- Article
Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et al.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1357, doi. 10.1111/bcp.13907
- By:
- Publication type:
- Article
Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1367, doi. 10.1111/bcp.13908
- By:
- Publication type:
- Article
Methadone dosing strategies in preterm neonates can be simplified.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1348, doi. 10.1111/bcp.13906
- By:
- Publication type:
- Article
Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model‐based meta‐analytic approach.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1215, doi. 10.1111/bcp.13904
- By:
- Publication type:
- Article
Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1337, doi. 10.1111/bcp.13903
- By:
- Publication type:
- Article
Handling interoccasion variability in model‐based dose individualization using therapeutic drug monitoring data.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1326, doi. 10.1111/bcp.13901
- By:
- Publication type:
- Article
Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic‐pharmacodynamic analysis of cinacalcet.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1312, doi. 10.1111/bcp.13900
- By:
- Publication type:
- Article
Fluid volume kinetics of 20% albumin.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1303, doi. 10.1111/bcp.13897
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1290, doi. 10.1111/bcp.13896
- By:
- Publication type:
- Article
Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1283, doi. 10.1111/bcp.13895
- By:
- Publication type:
- Article
Population/regional differences in efficacy of 3 drug categories (antidiabetic, respiratory and psychotropic agents) among East Asians: A retrospective study based on multiregional clinical trials.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1270, doi. 10.1111/bcp.13893
- By:
- Publication type:
- Article
Patterns of gabapentin and pregabalin use and misuse: Results of a population‐based cohort study in France.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1260, doi. 10.1111/bcp.13892
- By:
- Publication type:
- Article
Population pharmacokinetic–pharmacodynamic modelling of the relationship between testosterone and prostate specific antigen in patients with prostate cancer during treatment with leuprorelin.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1247, doi. 10.1111/bcp.13891
- By:
- Publication type:
- Article
Pharmacometrics and systems pharmacology for metabolic bone diseases.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1136, doi. 10.1111/bcp.13881
- By:
- Publication type:
- Article
Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1072, doi. 10.1111/bcp.13869
- By:
- Publication type:
- Article
Pharmacology of bisphosphonates.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1052, doi. 10.1111/bcp.13867
- By:
- Publication type:
- Article
The skeletal impact of cancer therapies.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1161, doi. 10.1111/bcp.13866
- By:
- Publication type:
- Article
Drugs for the treatment of metabolic bone diseases.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1049, doi. 10.1111/bcp.13857
- By:
- Publication type:
- Article
Open‐label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1239, doi. 10.1111/bcp.13856
- By:
- Publication type:
- Article
Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer‐induced bone loss.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1114, doi. 10.1111/bcp.13852
- By:
- Publication type:
- Article
Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1227, doi. 10.1111/bcp.13849
- By:
- Publication type:
- Article
Antiresorptive agents' bone‐protective and adjuvant effects in postmenopausal women with early breast cancer.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1125, doi. 10.1111/bcp.13834
- By:
- Publication type:
- Article
Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1180, doi. 10.1111/bcp.13823
- By:
- Publication type:
- Article
Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1169, doi. 10.1111/bcp.13820
- By:
- Publication type:
- Article
Genetic approaches to metabolic bone diseases.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1147, doi. 10.1111/bcp.13803
- By:
- Publication type:
- Article
Mechanisms that drive bone pain across the lifespan.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1103, doi. 10.1111/bcp.13801
- By:
- Publication type:
- Article
Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Regulatory aspects of the development of drugs for metabolic bone diseases – FDA and EMA perspective.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1208, doi. 10.1111/bcp.13791
- By:
- Publication type:
- Article
Update on pharmacologically‐relevant vitamin D analogues.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1095, doi. 10.1111/bcp.13781
- By:
- Publication type:
- Article
Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP).
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1199, doi. 10.1111/bcp.13777
- By:
- Publication type:
- Article
Osteoanabolic and dual action drugs.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1084, doi. 10.1111/bcp.13766
- By:
- Publication type:
- Article
Pharmacological management of X‐linked hypophosphataemia.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1188, doi. 10.1111/bcp.13763
- By:
- Publication type:
- Article
Side effects of drugs for osteoporosis and metastatic bone disease.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1063, doi. 10.1111/bcp.13759
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1045, doi. 10.1111/bcp.13680
- Publication type:
- Article